Increasing evidence indicates that a high-density collagen matrix reduces CD8+ T cell abundance [17] and that tumor-expressed collagens can suppress the immune response via the collagen receptor LAIR-1 [35, 36,]. This evidence concerns the gene LAIR1 and neoplasm.